• Home
• Responsibility
• CR Report 2005
• Managing CR
• Government and external affairs
• US lobbying expenditure

US lobbying expenditure

GSK spent $4,860,000 on federal lobbying activities in the US during 2005. This information is reported to the US Congress in accordance with the Lobbying Disclosure Act of 1995. This figure includes the salaries and cost of benefits for all employees registered to lobby the US government, as well as the cost of hiring any outside lobbying consultants, the cost associated with the support of lobbying contacts, such as planning activities, research and other background that is necessary. In addition the figure includes the cost of our running the GSK Washington DC government affairs office; support staff, the portion of trade association fees associated with federal lobbying and other costs of our activities in dealing with the US Federal government.

We do not collect data on lobbying expenditure, separately from other expenses in other countries.

Back to top